On Friday, May 23, 2025, IHU RespirERA organized an exceptional scientific evening in Nice focused on the latest developments in biomarkers for thoracic oncology. This event, which brought together nearly one hundred participants, provided an opportunity to review the most recent advances in diagnosis, personalized treatments, and precision medicine for lung cancer.
An evening of exchange and insight around biomarkers
Physicians, oncologists, biologists, pathologists, and key players in respiratory health innovation gathered in the prestigious setting of the Hôtel Le Saint Paul in Nice to attend a series of high-level scientific presentations. Discussions focused on key topics such as:
-
Les Targeted therapies,
-
Developments in immunotherapy,
-
Advances in Antibody-Drug Conjugates,
-
Advances in liquid biopsy as a tool for monitoring and detection
A welcoming atmosphere fostering expert dialogue
In addition to the scientific presentations, networking moments helped reinforce interactions. A welcome cocktail preceded the scientific session, followed by a dinner reception, encouraging conversations between participants, speakers, and industry partners present at dedicated stands. These partners had the opportunity to showcase their innovative solutions in connection with the development of personalized medicine.
A strong commitment to advancing respiratory disease research
Through this event, IHU RespirERA reaffirmed its key role in spreading knowledge and supporting scientific collaboration, by bringing together stakeholders in research, care, and innovation in thoracic oncology.
